Search results
Google, OpenAI Clash Over Internet Search, Artificial Intelligence Bragging Rights
Investor's Business Daily· 46 minutes agoGoogle received a modest boost from announcements at an AI-focused event for software developers,...
Q1 2024 DURECT Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 22 hours agoParticipants Tim Papp; CFO; DURECT Corp. James Brown; President and CEO; DURECT Corp. François Brisebois; Analyst; Oppenheimer & Co. Inc. Carl Byrnes; Analyst; Northland Capital ...
ARAMARK shares target raised by Oppenheimer on strong Q2 performance By Investing.com
Investing.com· 5 days agoOn Wednesday, Oppenheimer adjusted its outlook on ARAMARK Holdings (NYSE:ARMK) shares, increasing...
Kymera Therapeutics Inc (KYMR) Stock: Understanding the Volatility – News Heater
NewsHeater· 7 hours agoThe stock of Kymera Therapeutics Inc (KYMR) has gone down by -8.71% for the week, with a 2.04% rise in the past month and a 0.17% rise in the past quarter. The volatility ratio for the week ...
Wednesday's analyst calls: Goldman bullish on Alphabet's AI plans, EV stock gets an upgrade
CNBC· 4 hours agoPlease refresh every 20-30 minutes to view the latest posts.) Alphabet and a Chinese electric...
Quicklogic Corp [QUIK] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 7 hours agoA number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in mid August with a ‘”an Outperform”‘ rating. ROTH Capital ...
Monitoring HCI Group Inc
Knox Daily· 7 hours agoWilliam Blair upgraded its HCI Group Inc [HCI] rating to an Outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including ...
ITT Inc (ITT) may enjoy gains as insiders got busy in the recent days – Knox Daily
Knox Daily· 7 hours agoUBS also remained covering ITT and has increased its forecast on April 08, 2022 with a “Buy” recommendation from previously “Neutral” rating. Oppenheimer revised its rating ...
Oppenheimer Fellows to Gain Broader View of National Labs
Newswise· 2 days agoNuclear physicist Douglas Higinbotham, operations director for the...
Viridian Therapeutics shares target cut by Oppenheimer By Investing.com
Investing.com· 6 days agoOn Thursday, Oppenheimer adjusted its price target for Viridian Therapeutics (NASDAQ:VRDN), a...
